Biography and Research Information
OverviewAI-generated summary
Ian J Tackett's research has focused on the molecular mechanisms underlying cancer response to immunotherapy. Their recent publication, "ATF6 activation promotes ICB response in melanoma" (2025), investigates how the ATF6 pathway influences immune checkpoint blockade (ICB) efficacy in melanoma patients. This work involves studying cellular signaling pathways and their impact on tumor microenvironments. Tackett collaborates with researchers at the University of Arkansas for Medical Sciences, including Brian Koss, Katherine Wallis, Nathan L. Avaritt, and Megan R. Reed. Their recent activity indicates ongoing engagement in the field.
Metrics
- Publications: 1
Selected Publications
-
691 ATF6 activation promotes ICB response in melanoma (2025)
Collaboration Network
Top Collaborators
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
- 691 ATF6 activation promotes ICB response in melanoma
Similar Researchers
Based on overlapping research topics